Rady Johnson just Sold 27,323 shares of Pfizer Inc. (PFE), be careful if you are long!; Mueller Water Products (MWA)’s Sentiment Is 0.98

March 15, 2018 - By Vivian Park

Insider transaction amounting to a total of $998,666 US Dollars was disclosed in a public form submitted to the SEC on 14/03/2018. According to which, Rady Johnson, the Executive Vice President of Pfizer Inc also an insider of the New York-based Pfizer Inc had sold exactly 27,323 shares – ( at $36.6 for a share ). At the moment, Rady Johnson has ownership of 48,179 shares or about 0.0008% of the Company’s market capitalization (total value of the shares outstanding).

Mueller Water Products, Inc. manufactures and markets services and products for the use in transmission, distribution, and measurement of water in the United States, Canada, and internationally. The company has market cap of $1.81 billion. The firm operates in three divisions: Mueller Co., Anvil, and Mueller Technologies. It has a 10.63 P/E ratio. The Mueller Co. segment offers valves for water and gas systems, including iron gate, butterfly, tapping, check, knife, plug, and ball valves; dry-barrel and wet-barrel fire hydrants; pipe repair products, such as clamps and couplings used to repair leaks under the Mueller and Jones brand names; small valves, meter bars, and line stopper fittings for use in gas systems; and machines and tools for tapping, drilling, extracting, installing, and stopping-off.

The stock increased 0.53% or $0.06 during the last trading session, reaching $11.4. About 763,561 shares traded. Mueller Water Products, Inc. (MWA) has risen 8.65% since March 15, 2017 and is uptrending. It has underperformed by 8.05% the S&P500.

Marathon Partners Equity Management Llc holds 3.07% of its portfolio in Mueller Water Products, Inc. for 545,000 shares. Water Asset Management Llc owns 461,591 shares or 2.96% of their US portfolio. Moreover, Impax Asset Management Ltd has 2.05% invested in the company for 5.24 million shares. The New York-based Corsair Capital Management L.P. has invested 1.42% in the stock. Lorber David A, a Connecticut-based fund reported 9,154 shares.

Analysts await Mueller Water Products, Inc. (NYSE:MWA) to report earnings on April, 26. They expect $0.10 EPS, up 11.11% or $0.01 from last year’s $0.09 per share. MWA’s profit will be $15.88 million for 28.50 P/E if the $0.10 EPS becomes a reality. After $0.06 actual EPS reported by Mueller Water Products, Inc. for the previous quarter, Wall Street now forecasts 66.67% EPS growth.

Investors sentiment increased to 1.06 in Q3 2017. Its up 0.10, from 0.96 in 2017Q2. It increased, as 53 investors sold Pfizer Inc. shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Bedrijfstakpensioenfonds Voor De Media Pno accumulated 0.59% or 147,186 shares. Moreover, Cambridge Tru has 0.29% invested in Pfizer Inc. (NYSE:PFE) for 119,043 shares. Autus Asset Limited Liability Corp holds 7,240 shares or 0.05% of its portfolio. Oppenheimer Asset Incorporated has invested 0.65% of its portfolio in Pfizer Inc. (NYSE:PFE). Arizona State Retirement Systems reported 0.7% in Pfizer Inc. (NYSE:PFE). Bkd Wealth Advisors Ltd owns 0.39% invested in Pfizer Inc. (NYSE:PFE) for 100,213 shares. Carroll Fin Assoc Inc stated it has 0.96% in Pfizer Inc. (NYSE:PFE). Cypress Capital Grp Inc stated it has 0.75% in Pfizer Inc. (NYSE:PFE). Johnson Financial Grp Incorporated reported 134,527 shares. First Heartland Consultants Inc holds 0.34% or 39,180 shares in its portfolio. Verity & Verity Lc holds 210,959 shares or 2.2% of its portfolio. Trust Limited Liability Com stated it has 6,275 shares or 0.2% of all its holdings. Bremer Association reported 39,933 shares or 0.4% of all its holdings. Boyd Watterson Asset Mgmt Ltd Liability Com Oh reported 75,560 shares. Stonebridge Capital Advsr Limited Company reported 0.51% of its portfolio in Pfizer Inc. (NYSE:PFE).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1. They expect $0.73 EPS, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.35 billion for 12.45 P/E if the $0.73 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. The company has market cap of $216.39 billion. It operates through two divisions, Pfizer Innovative Health and Pfizer Essential Health (EH). It has a 10.34 P/E ratio. The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care.

Since December 15, 2017, it had 0 insider buys, and 10 sales for $10.15 million activity. Dolsten Mikael sold 64,587 shares worth $2.39M. Another trade for 26,779 shares valued at $986,292 was made by HILL CHARLES H on Wednesday, February 28. CORNWELL W DON sold $64,679 worth of Pfizer Inc. (NYSE:PFE) on Monday, February 26. $1.24 million worth of Pfizer Inc. (NYSE:PFE) shares were sold by SUSMAN SALLY. JOHNSON RADY A had sold 8,000 shares worth $296,560. Shares for $249,750 were sold by MACKENZIE ALEXANDER R. LUND-JURGENSEN KIRSTEN sold $353,677 worth of Pfizer Inc. (NYSE:PFE) on Saturday, February 24.

The stock decreased 1.09% or $0.4 during the last trading session, reaching $36.35. About 22.18 million shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since March 15, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $39.80’s average target is 9.49% above currents $36.35 stock price. Pfizer had 75 analyst reports since July 29, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of PFE in report on Monday, September 18 with “Buy” rating. The rating was maintained by Leerink Swann on Wednesday, January 31 with “Market Perform”. The stock has “Hold” rating by Societe Generale on Wednesday, April 6. Jefferies maintained the stock with “Buy” rating in Tuesday, June 14 report. The firm has “Buy” rating by Jefferies given on Thursday, July 14. The stock of Pfizer Inc. (NYSE:PFE) earned “Market Perform” rating by Leerink Swann on Monday, May 2. The stock of Pfizer Inc. (NYSE:PFE) has “Market Perform” rating given on Wednesday, November 2 by BMO Capital Markets. The stock has “Buy” rating by Jefferies on Thursday, August 4. The firm has “Overweight” rating by Barclays Capital given on Tuesday, November 29. Jefferies maintained the shares of PFE in report on Wednesday, August 16 with “Hold” rating.